Pharmacogenetic study of the effects of raloxifene on negative symptoms of postmenopausal women with schizophrenia: A double-blind, randomized, placebo-controlled trial Article

Labad, Javier, Martorell, Lourdes, Huerta-Ramos, Elena et al. (2016). Pharmacogenetic study of the effects of raloxifene on negative symptoms of postmenopausal women with schizophrenia: A double-blind, randomized, placebo-controlled trial . EUROPEAN NEUROPSYCHOPHARMACOLOGY, 26(10), 1683-1689. 10.1016/j.euroneuro.2016.08.006

International Collaboration

cited authors

  • Labad, Javier; Martorell, Lourdes; Huerta-Ramos, Elena; Cobo, Jesus; Vilella, Elisabet; Rubio-Abadal, Elena; Garcia-Pares, Gemma; Creus, Marta; Nunez, Cristian; Ortega, Laura; Miquel, Eva; Usall, Judith

sustainable development goals

authors

publication date

  • October 1, 2016

published in

keywords

  • BREAST-CANCER
  • Clinical Neurology
  • ESTROGEN
  • GLUCURONIDATION
  • Genetics
  • Life Sciences & Biomedicine
  • METABOLISM
  • Negative symptoms
  • Neurosciences
  • Neurosciences & Neurology
  • POLYMORPHISM
  • Pharmacogenetics
  • Pharmacology & Pharmacy
  • Postmenopause
  • Psychiatry
  • RECEPTOR-ALPHA GENE
  • RISK
  • Raloxifene
  • Schizophrenia
  • Science & Technology
  • UGT1A8
  • VARIANTS
  • XBAI

Digital Object Identifier (DOI)

publisher

  • ELSEVIER SCIENCE BV

start page

  • 1683

end page

  • 1689

volume

  • 26

issue

  • 10